LipoCure
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 12235, Jerusalem, Jerusalem, 9112...Phone Number
(800) 978-1855Website
www.lipocurerx.comRevenue
<$5 MillionIndustry
About LipoCure
LipoCure is focused on developing highly-potent therapeutics using proprietary liposome-based nano-drugs that feature novel drug-loading capabilities and drug-release mechanisms. Their innovative platform technology enhances the efficacy and safety of treatments for inflammatory diseases and cancers by improving drug delivery and reducing side effects. Founded by Professor Barenholz, co-developer of the anti-cancer drug Doxil, LipoCure aims to provide more effective therapies for patients suffering from various conditions. The company’s unique approach leverages advanced bioenergetics and nano-technology to transform small-molecule drugs into superior nano-drugs.Explore more
SIC Code 28,283NAICS Code 32,325Show moreLipoCure Org Chart
Compare Similar Companies to LipoCure
Compare insights from companies similar to LipoCure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
LipoCure Tech Stack
A closer look at the technologies used by LipoCure
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LipoCure
Sign Up For FreeTo access detailed company insights
LipoCure is focused on developing highly-potent therapeutics using proprietary liposome-based nano-drugs that feature novel drug-loading capabilities and drug-release mechanisms. Their innovative platform technology enhances the efficacy and safety of treatments for inflammatory diseases and cancers by improving drug delivery and reducing side effe... Read More